Endothelial, Vascular and Sympathetic Alterations as Therapeutic Targets in Chronic Heart Failure

Area of Science:

• Cardiovascular Medicine
• Vascular Biology
• Heart Failure Pathophysiology

Background:

• Chronic heart failure (CHF) is associated with significant vascular and sympathetic nervous system dysfunction.
• Key alterations include reduced arterial distensibility, endothelial dysfunction, decreased compliance, increased stiffness, and sympathetic overactivation.
• These abnormalities negatively impact CHF prognosis and disease progression.

Purpose of the Study:

• To review therapeutic interventions targeting vascular and sympathetic alterations in CHF.
• To elucidate the mechanisms underlying the vascular/sympathetic effects of various treatments.
• To discuss unmet therapeutic goals related to endothelial and adrenergic targets.

Main Methods:

• Comprehensive literature review of non-pharmacological, pharmacological, and device-based treatments for CHF.
• Analysis of studies investigating the impact of interventions on vascular and sympathetic parameters.
• Examination of mechanistic pathways linking treatments to vascular/sympathetic modulation.

Main Results:

• Various interventions demonstrate potential to ameliorate vascular and sympathetic dysfunction in CHF.
• Non-pharmacological, pharmacological, and device-based approaches offer distinct mechanisms for improvement.
• Understanding these mechanisms is crucial for optimizing CHF management.

Conclusions:

• Targeting vascular and sympathetic abnormalities is a key strategy in managing CHF.
• Further research is needed to address unmet therapeutic goals concerning endothelial and adrenergic pathways.
• Personalized treatment approaches may improve outcomes for patients with CHF.